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LETTER TO THE EDITORS
ANTIPHOSPHOLIPID ANTIBODIES, THROMBOSIS,
AND ADENOCARCINOMA
Nadia Schiavo, Andrei Lemos Lottermann, Fernanda Pires Costa, and Henrique
Luiz Staub
Antiphospholipid antibodies (APA) are associated with
a common thrombotic diathesis of young adults. The
antiphospholipid syndrome (APS), and APA have also been
observed in patients with infections and cancer1. We herein
describe the occurrence of APA in two cases of adenocarci-
noma, one of them unusual.
The first patient, a 60-year-old man, presented deep vein
thrombosis (DVT) of the lower limb followed by pulmonary
thromboembolism (PTE) in May 2003. Even though the
patient was on an international normalized ratio (INR) for
warfarin of 1.99, a new episode of lower limb DVT and PTE
developed a month later. An abdominal computed tomog-
raphy (CT) revealed a thrombus in the aorta. The lupus an-
ticoagulant (LA) factor tested positive, but the
anticardiolipin (aCL) IgG, IgM, and IgA antibody tested
negative.1 Antinuclear antibodies (ANA) and rheumatoid
factors (RF) were absent. Two months later, he developed
DVT of the other lower limb in spite of a INR of 3.7. After
3 weeks, DVT of the upper right limb was noticed. At that
time, the INR was 3.6. The LA test was negative. Supracla-
vicular lymphadenopathy was observed two months later.
Biopsy revealed metastatic lung adenocarcinoma. A lung
CT, previously inconclusive, showed disseminated nodules.
The patient underwent chemotherapy. By April 2004, a
lower cava vein filter was successfully introduced to pre-
vent PTE. Oral anticoagulation was maintained until his re-
cent death due to a lung infection.
The second patient, a 73-year-old hypertensive man, was
first seen by the rheumatologist in 1996 due to shoulder
bursitis. Routine tests disclosed a very high level (77.5
units) of prostate surface antigen (PSA). A biopsy confirmed
a prostate adenocarcinoma. The patient was kept on estrogen
therapy until 1997. In 1998 a lower limb DVT was diag-
nosed. The IgA aCL antibody test was positive (26 units;
reference value for negative test below 15 units). Tests for
LA, ANA, and RF were negative. Oral anticoagulation was
introduced. In 1999, the patient suffered a myocardial inf-
arction, irrespective of an INR of 2.5. In October 2003, only
IgM aCL antibodies were detected in moderate titers (21
units). Moderate levels of IgM and IgA aCL antibodies (20
and 21 units, respectively) are currently detected. He has
been asymptomatic, and the last INR was 4.2.
Probable APS was diagnosed in the first patient.1 He had
a thrombotic diathesis and transient LA. However, the lat-
ter LA assays were run after chemotherapy for the lung
tumor. In the second patient, APS was confirmed by clini-
cal features and 2 positive IgM aCL assays.1 Interestingly,
“non-classical” IgA aCL was the only isotype detected in
the first test. The diagnostic value of IgA aCL antibodies
for patients with thrombosis has been a matter of debate.2,3
Estrogen therapy for prostate carcinoma might have trig-
gered APA and APS in this second patient.
“True” APS has been linked to a variety of malignan-
cies.4-6 The spectrum of APS-related solid tumors includes
renal cell carcinoma,7 gastric cancer,8 and
cholangiocarcinoma.9 One patient with breast cancer and
another with colorectal carcinoma experienced dramatic
exacerbation of APS after surgery. 10
The association of APS with lung tumors is of interest.
A patient with recurrent cerebral ischemia, DVT, and APA
was later found to have a lung adenocarcinoma.11 Similarly
to our first patient, thrombosis preceded the lung tumor and
occurred in spite of a high INR. Venous gangrene and aCL
Department of Rheumatology, São Lucas Hospital, Pontiphical Catholic
University of Rio Grande do Sul – Rio Grande do Sul/PA, Brazil.
E-mail: reumato@pucrs.br
11.pmd 27/5/2005, 16:08257
258
CLINICS 2005;60(3):257-8Antiphospholipid antibodies, thrombosis, and adenocarcinoma
Schiavo N et al.
antibodies were described in another case of lung adeno-
carcinoma.12 Severe exacerbation of APS was seen in a pa-
tient following lung adenocarcinoma biopsy.13 “Cata-
strophic” APS was reported in an autopsy case of lung ad-
enocarcinoma.14 A patient with adrenal insufficiency and
APA developed after 6 months a polymetastatic bronchop-
ulmonary tumor.15 Simultaneous occurrence of thrombocy-
topenia and LA was described in a patient with primary ad-
enocarcinoma of the bronchus. 16
Prostate carcinoma has been reported in patients with
DVT, but a test for aCL antibodies were not performed in
that study.17 Although APA has been found in cases of lung
adenocarcinoma,11-16 APA has not been clearly linked to pros-
tate carcinoma so far. Owing to the previous estrogen therapy
in our patient, an association of prostate carcinoma with
APS is only hypothetical. As opposed to the patient with
lung adenocarcinoma, our patient with prostate carcinoma
presented thrombosis well after the appearence of the tumor.
APS might be one of the etiologies for tumor-related throm-
bosis. However, coincidence of these two entities can not
be ruled out in older patients. The presence of APA might
eventually be regarded as an epiphenomenon of cancer.
Overall, a suspicion of neoplasms in older patients with APS
or APA seems appropriate. Lung and prostate adenocarci-
noma could be part of this context.
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